Home › Research › Disease mechanisms
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long, David M. Holtzman. Cell, 2019-09-26
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This study reviews recent advances in understanding the complex pathobiology of Alzheimer disease and discusses current treatment strategies. It examines the primary neuropathologic criteria for diagnosis alongside recent discoveries highlighting other cellular and molecular processes. Additionally, the study notes that no disease-modifying treatment currently exists and that numerous clinical trials have failed to demonstrate benefits.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Long, J. M., & Holtzman, D. M. (2019). Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. https://doi.org/10.1016/j.cell.2019.09.001
Vancouver
Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019. doi:10.1016/j.cell.2019.09.001. PMID: 31564456.
BibTeX
@article{long2019-31564456,
author = {Long, Justin M. and Holtzman, David M.},
title = {{Alzheimer Disease: An Update on Pathobiology and Treatment Strategies}},
journal = {Cell},
year = {2019},
doi = {10.1016/j.cell.2019.09.001},
pmid = {31564456},
url = {https://doi.org/10.1016/j.cell.2019.09.001}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology.
- The presence of extracellular β-amyloid deposition as neuritic plaques and intracellular accumulation of hyperphosphorylated tau as neurofibrillary tangles remains the primary neuropathologic criteria for AD diagnosis.
- A number of recent fundamental discoveries highlight important pathological roles for other critical cellular and molecular processes.
Why it matters
An update on the disease biology of Alzheimer's disease and on strategies for treating it.
How this study scored 59/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 56 of the 95 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Cell) |
| Journal's citation record | 4 / 4 | Cell: journal h-index 1,220 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2019 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 3,201 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 355.7 citations a year over 9 year(s) since 2019 |
| Impact for its field and year | 6 / 6 | Cited 169.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 4 / 4 | Cited 1,481 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author David M. Holtzman: h-index 206 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Washington University in St. Louis: institution h-index 1,962 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31564456) |
| Free to read | 2 / 2 | Free to read |
| Points | 56 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 56 of the 95 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Disease mechanisms from nearby years
Also in Disease mechanisms
135 studies in the library are filed under Disease mechanisms with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Disease mechanisms hub.